Compare Stocks: STIM, INMD, AVR, and SIBN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVR Anteris Technologies Global	$8.16 -3.1%	$8.65	$3.30 ▼ $11.06	$795.26M	1.8	567,143 shs	1.81 million shs
INMD InMode	$14.35 -1.3%	$15.06	$12.72 ▼ $16.74	$824.85M	1.86	486,971 shs	758,084 shs
SIBN SiBone	$18.09 +0.3%	$18.38	$11.48 ▼ $21.89	$802.27M	0.7	552,770 shs	861,412 shs
STIM Neuronetics	$2.90 -2.4%	$2.55	$0.80 ▼ $3.44	$220.97M	1.16	1.26 million shs	1.12 million shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVR Anteris Technologies Global	0.00%	-2.28%	-11.78%	-16.56%	+45.45%
INMD InMode	0.00%	-3.69%	-3.82%	+7.09%	-3.88%
SIBN SiBone	0.00%	-1.58%	-7.14%	+14.20%	+22.98%
STIM Neuronetics	0.00%	-4.29%	-6.15%	+135.77%	+1.75%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVR Anteris Technologies Global	$8.16 -3.1%	$8.65	$3.30 ▼ $11.06	$795.26M	1.8	567,143 shs	1.81 million shs
INMD InMode	$14.35 -1.3%	$15.06	$12.72 ▼ $16.74	$824.85M	1.86	486,971 shs	758,084 shs
SIBN SiBone	$18.09 +0.3%	$18.38	$11.48 ▼ $21.89	$802.27M	0.7	552,770 shs	861,412 shs
STIM Neuronetics	$2.90 -2.4%	$2.55	$0.80 ▼ $3.44	$220.97M	1.16	1.26 million shs	1.12 million shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVR Anteris Technologies Global	0.00%	-2.28%	-11.78%	-16.56%	+45.45%
INMD InMode	0.00%	-3.69%	-3.82%	+7.09%	-3.88%
SIBN SiBone	0.00%	-1.58%	-7.14%	+14.20%	+22.98%
STIM Neuronetics	0.00%	-4.29%	-6.15%	+135.77%	+1.75%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVR Anteris Technologies Global	2.60	Moderate Buy	$16.00	96.08% Upside
INMD InMode	2.00	Hold	$16.00	11.50% Upside
SIBN SiBone	2.71	Moderate Buy	$24.17	33.59% Upside
STIM Neuronetics	2.67	Moderate Buy	$4.67	60.92% Upside

Current Analyst Ratings Breakdown

Latest STIM, INMD, AVR, and SIBN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/17/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
9/14/2026	STIM Neuronetics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/11/2026	STIM Neuronetics	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy
9/11/2026	STIM Neuronetics	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$5.00
9/9/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
8/26/2026	AVR Anteris Technologies Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/20/2026	SIBN SiBone	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/14/2026	AVR Anteris Technologies Global	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$15.00
8/11/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$5.00 ➝ $6.00
8/6/2026	INMD InMode	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/5/2026	SIBN SiBone	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVR Anteris Technologies Global	$1.91M	416.37	N/A	N/A	($0.01) per share	-816.00
INMD InMode	$370.49M	2.23	$1.49 per share	9.62	$10.78 per share	1.33
SIBN SiBone	$200.93M	3.99	N/A	N/A	$4.09 per share	4.42
STIM Neuronetics	$149.16M	1.48	N/A	N/A	$0.38 per share	7.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVR Anteris Technologies Global	-$94.14M	-$1.95	N/A	N/A	N/A	-4,619.27%	-77.69%	-67.99%	11/11/2026 (Estimated)
INMD InMode	$93.83M	$1.23	11.67	N/A	N/A	20.69%	11.99%	10.60%	10/28/2026 (Estimated)
SIBN SiBone	-$18.90M	-$0.34	N/A	N/A	N/A	-6.85%	-8.23%	-6.07%	11/9/2026 (Estimated)
STIM Neuronetics	-$39M	-$0.44	N/A	N/A	N/A	-19.62%	-125.11%	-22.15%	11/3/2026 (Estimated)

Latest STIM, INMD, AVR, and SIBN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2026	Q2 2026 TU	AVR Anteris Technologies Global	-$0.2073	-$0.30	-$0.0927	-$0.30	$1.50 million	$1.01 million
8/11/2026	Q2 2026	STIM Neuronetics	-$0.1230	-$0.05	+$0.0730	-$0.05	$40.17 million	$41.57 million
8/5/2026	Q2 2026	INMD InMode	$0.3460	$0.35	+$0.0040	$0.29	$94.89 million	$95.59 million
8/3/2026	Q2 2026	SIBN SiBone	-$0.1495	-$0.09	+$0.0595	-$0.09	$55.34 million	$56.01 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
SIBN SiBone	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVR Anteris Technologies Global	N/A	14.20	14.20
INMD InMode	N/A	8.18	7.28
SIBN SiBone	0.20	9.15	7.55
STIM Neuronetics	2.84	1.88	1.69

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVR Anteris Technologies Global	N/A
INMD InMode	68.04%
SIBN SiBone	98.11%
STIM Neuronetics	53.59%

Insider Ownership

Company	Insider Ownership
AVR Anteris Technologies Global	4.50%
INMD InMode	6.92%
SIBN SiBone	4.00%
STIM Neuronetics	8.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVR Anteris Technologies Global	174	97.46 million	93.07 million	N/A
INMD InMode	660	57.48 million	53.50 million	Optionable
SIBN SiBone	376	44.35 million	42.58 million	Optionable
STIM Neuronetics	658	76.20 million	69.80 million	Optionable

STIM, INMD, AVR, and SIBN Headlines

Recent News About These Companies

Neuronetics stock holds after August 11 earnings beat

3 hours ago | ad-hoc-news.deA

BTIG Research Reiterates Buy Rating for Neuronetics (NASDAQ:STIM)

September 17 at 12:53 PM | marketbeat.com

Analysts Set Neuronetics, Inc. (NASDAQ:STIM) PT at $4.50

September 16, 2026 | americanbankingnews.com

Neuronetics (NASDAQ:STIM) Coverage Initiated at B. Riley Financial

September 13, 2026 | americanbankingnews.com

B Riley Securities initiates coverage of Neuronetics at buy

September 12, 2026 | msn.com

B. Riley Initiates Neuronetics at Buy With $5 Price Target

September 11, 2026 | marketscreener.comM

Neuronetics (NASDAQ:STIM) Now Covered by B. Riley Financial

September 11, 2026 | marketbeat.com

Neuronetics, Inc. (NASDAQ:STIM) Receives Average Recommendation of "Moderate Buy" from Brokerages

September 11, 2026 | marketbeat.com

BTIG Research Reaffirms "Buy" Rating for Neuronetics (NASDAQ:STIM)

September 9, 2026 | marketbeat.com

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

September 8, 2026 | globenewswire.com

BlackRock Inc. Invests $776,000 in Neuronetics, Inc. $STIM

September 7, 2026 | marketbeat.com

18,540,488 Shares in Neuronetics, Inc. $STIM Purchased by Madryn Asset Management LP

August 29, 2026 | marketbeat.com

Neuronetics (STIM) Q2 2026 Earnings Call Transcript

August 18, 2026 | finance.yahoo.com

Neuronetics (NASDAQ:STIM) Major Shareholder Acquires 14,000 Shares of Stock

August 18, 2026 | insidertrades.com

Neuronetics, Inc. (STIM) Q2 FY2026 earnings call transcript

August 12, 2026 | finance.yahoo.com

Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ...

August 12, 2026 | finance.yahoo.com

Neuronetics: Q2 Earnings Snapshot

August 11, 2026 | wtop.comW

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

August 11, 2026 | markets.businessinsider.com

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

Neuronetics narrows Q2 loss as Greenbrook growth drives 9% revenue increase

August 11, 2026 | msn.com

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

August 11, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

STIM, INMD, AVR, and SIBN Company Descriptions

Anteris Technologies Global NASDAQ:AVR

$8.16 -0.26 (-3.09%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$8.21 +0.05 (+0.60%)

As of 09/18/2026 07:30 PM Eastern

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

InMode NASDAQ:INMD

$14.35 -0.19 (-1.31%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$14.52 +0.17 (+1.16%)

As of 09/18/2026 07:50 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

SiBone NASDAQ:SIBN

$18.09 +0.05 (+0.28%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$18.08 -0.02 (-0.08%)

As of 09/18/2026 07:30 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Neuronetics NASDAQ:STIM

$2.90 -0.07 (-2.36%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$2.89 -0.01 (-0.45%)

As of 09/18/2026 07:55 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest STIM, INMD, AVR, and SIBN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest STIM, INMD, AVR, and SIBN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

STIM, INMD, AVR, and SIBN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

STIM, INMD, AVR, and SIBN Company Descriptions

Anteris Technologies Global NASDAQ:AVR

InMode NASDAQ:INMD

SiBone NASDAQ:SIBN

Neuronetics NASDAQ:STIM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest STIM, INMD, AVR, and SIBN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest STIM, INMD, AVR, and SIBN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

STIM, INMD, AVR, and SIBN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

STIM, INMD, AVR, and SIBN Company Descriptions

Anteris Technologies Global NASDAQ:AVR

InMode NASDAQ:INMD

SiBone NASDAQ:SIBN

Neuronetics NASDAQ:STIM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools